Generic drugmakers settle inflated prices claim by paying $18 million and adopting antitrust compliance reforms in a decade-long Connecticut lawsuit.

But a ProPublic investigation found that the FDA rarely tests the quality of generic drugs, many of them manufactured overseas. National reporter Debbie Cenziper of ProPublica was one of the authors ...